Niagen Bioscience, Inc. NAGE
2.07 USD -0.04 (-1.66%)
At closeNov 9, 2026, 6:24 AM EST
2.08 +0.01 +0.48%
Pre-market · Nov 9, 6:24 AM ET
2.04 Day range 2.11
2.04 52-week range 7.28
- YTD
- -67.45%
- 1 year
- -69.74%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 129.42M | 99.60M | 83.57M | 72.05M | 67.45M | |
| 83.19M | 61.59M | 50.78M | 42.80M | 41.49M | |
| 16.28M | 7.73M | -5.60M | -18.63M | -27.07M | |
| 17.38M | 8.55M | -4.94M | -16.54M | -27.13M | |
| 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 64.79M | 44.66M | 27.32M | 20.44M | 28.22M | |
| 106.41M | 68.28M | 54.96M | 54.06M | 57.84M | |
| 29.87M | 22.18M | 26.51M | 25.39M | 26.11M | |
| 2.82M | 2.65M | 3.28M | 4.26M | 4.70M | |
| 76.53M | 46.09M | 28.46M | 28.67M | 31.73M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 13.50M | 12.11M | 7.12M | -15.10M | -24.16M | |
| -292.00K | -143.00K | -143.00K | -334.00K | -409.00K | |
| 6.92M | 5.37M | -90.00K | 7.65M | 36.09M | |
| -292.00K | -143.00K | -143.00K | -334.00K | -409.00K | |
| 20.13M | 17.34M | 6.88M | -7.78M | 11.52M |